# Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

> **NCT00070304** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 33 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00070304
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-09
- **Final completion:** —
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070304, "Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00070304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*